-
DATROWAY® Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung Cancer
01 Jun 2025 13:06 GMT
… non-small cell lung cancer have limited treatment options and often … TROPION-Breast01 trial.
About the DATROWAY Clinical Development Program
A … or FDA at 1-800-FDA-1088 or fda.gov… Prescribing Information, including the Medication Guide.
About Daiichi Sankyo …
-
IMFINZI® (durvalumab) regimen reduced risk of progression, recurrence or death by 29% in early-stage gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial
01 Jun 2025 12:10 GMT
… frequently develop recurrent disease. Results from the MATTERHORN trial … , consider using pre-medications with subsequent doses.
… treatment of adult patients with extensive-stage small cell lung cancer … as determined by an FDA-approved test.
IMFINZI in …
-
NHS Scotland launches AI trial to help detect lung cancer and strokes in X-rays - 'Huge potential!'
01 Jun 2025 06:00 GMT
… Scottish health boards are trialing a revolutionary artificial … to detect signs of lung cancer and head trauma.
Scans … Scottish health boards are trialing a revolutionary artificial intelligence … the end of accelerated treatment pathways where increased …
-
Harnessing the Tumor Microenvironment for Enhanced Cancer Treatment
01 Jun 2025 04:02 GMT
… essential roles in embryonic development as they are important … In March 2022, the FDA approved a fixed-dose combination … Myers Squibb) for the treatment of metastatic melanoma, marking … immunotherapy for non-small cell lung cancer patients. Science. 2024;384 …
-
Breakthrough Clinical Data for LBL-024 in First-Line Treatment of Advanced EP-NEC Unveiled at 2025 ASCO Oral Session
01 Jun 2025 03:05 GMT
… treatment for EP-NEC. Our strategy prioritizes efficient development … a single-arm pivotal trial in China, marking … Food and Drug Administration (FDA) for neuroendocrine carcinoma (November … types, including small cell lung cancer (SCLC), ovarian cancer (OC …
-
Adebrelimab in Small Cell Lung Cancer: From Current Advances to Emerging Combination Strategy and Challenge
31 May 2025 15:01 GMT
… development of adebrelimab for the treatment of extensive-stage small cell lung cancer … blocking, monoclonal antibody drugs can also bind … extensive-stage small cell lung cancer; FDA, Food and Drug … cell lung cancer: a randomized phase 3 trial. Nat Med. 2024 …
-
Assay predicts adjuvant chemotherapy benefit in early-stage non-small cell lung cancer
31 May 2025 15:11 GMT
… .
Patients with early-stage lung cancer often undergo surgery. Less … it.
The AIM HIGH trial included adults with completely resected … .
When the assay was developed, results from the validation … often don’t receive adjuvant treatment. The interim results from …
-
Merck, Daiichi Sankyo withdraw US appication for patritumab deruxtecan for advanced or metastatic EGFR-mutated non-small cell lung cancer
31 May 2025 13:11 GMT
… Lung01 Phase 2 trial for the treatment of adult patients … HERTHENA-Lung02 Phase 3 trial, including previously reported … kinase inhibitor (TKI) treatment. Patients achieving tumor response … to guide our continued development in lung cancer. We remain confident …
-
Mythic Therapeutics Presents Compelling Efficacy Data from its Phase 1 KisMET-01 Study Supporting Best-in-Class Potential of Novel cMET- ADC, MYTX-011, in Non-Small Cell Lung Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting
31 May 2025 12:30 GMT
… developing next-generation antibody-drug conjugate (ADC) therapies for the treatment … in Part 2 of the trial.
“The early data from … durable responses in patients with lung cancer, together with a well- … Phase 1 KisMET-01 clinical trial, a first-in-human, …
-
Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
31 May 2025 19:22 GMT
… nab-paclitaxel alone. The trial met its primary endpoint, … , trends, and determinants. Chin Med J (Engl) 2022; 135: … are focused on discovering, developing, and commercializing innovative products … the treatment of glioblastoma, non-small cell lung cancer and …
About
© 1995-2025